These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2164749)

  • 1. Biochemical effects of GYKI-12 743.
    Bakonyi A; Tömösközi Z; Heiczman A; Horváth EJ; Arányi P; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():19-20. PubMed ID: 2164749
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular and cardiac electrophysiological activity of GYKI-12 743 in isolated tissue preparations.
    Jednákovits A; Kovács A; Bódi I; Jaszlits L; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():157-8. PubMed ID: 1973560
    [No Abstract]   [Full Text] [Related]  

  • 3. GYKI-12 743, a novel antihypertensive compound with special alpha-adrenergic blocking profile.
    Jaszlits L; Rabloczky G; Csókás G; Bódi I; Kürthy M; Horváth E; Kovács A; Jednákovits A; Arányi P; Mátyus P
    Acta Physiol Hung; 1990; 75 Suppl():155-6. PubMed ID: 1973559
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of the predominant vascular postsynaptic alpha-adrenergic blocking capacity of GYKI-12 743 in isolated organs and pithed rats.
    Horváth E; Bódi I; Jaszlits L; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():145-6. PubMed ID: 1973558
    [No Abstract]   [Full Text] [Related]  

  • 5. Demonstration of the potassium channel opening activity of GYKI-12743 by 86Rb+ efflux studies.
    Bakonyi A; Horváth EJ
    Acta Physiol Hung; 1994; 82(4):295-300. PubMed ID: 7785439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha-adrenoblocking activity of a newly synthesized derivative of 1,4-benzodioxane].
    Staneva D; Spasov V; Ivanov D
    Eksp Med Morfol; 1984; 23(2):87-91. PubMed ID: 6147242
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and hypotensive activity of some heterocyclic analogues of GYKI-12 743.
    Mátyus P; Kasztreiner E; Diesler E; Behr A; Varga I; Kosáry J; Rabloczky G; Jaszlits L
    Arch Pharm (Weinheim); 1994 Sep; 327(9):543-6. PubMed ID: 7979923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of single administration of adrenergic alpha receptor blockader piroxan on bronchial patency in patients with bronchial asthma].
    Zonis IaM; Zonis BIa
    Ter Arkh; 1981; 53(11):108-10. PubMed ID: 6122273
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo selectivity of prazosin but not of WB4101 for postsynaptic alpha-1 adrenoceptors.
    Massingham R; Dubocovich ML; Shepperson NB; Langer SZ
    J Pharmacol Exp Ther; 1981 May; 217(2):467-74. PubMed ID: 6112260
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of piperoxan and 2-(2-imidazolinyl)-1, 4-benzodioxane (170 150) on pre- and postsynaptic receptors in the rat].
    Mouillé P; Dabiré H; Fournier B; Schmitt H
    J Pharmacol; 1982; 13(3):389-97. PubMed ID: 6290793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between prazosin and benzodioxan antihypertensives (R 28935 and R 29814); a competition for central alpha 1-adrenoceptors [proceedings].
    Kwa HY; Timmermans PB; Van Zwieten PA
    Br J Pharmacol; 1980 Jan; 68(1):138P-139P. PubMed ID: 6244026
    [No Abstract]   [Full Text] [Related]  

  • 12. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spiroxatrine: a selective serotonin1A receptor antagonist.
    Nelson DL; Taylor EW
    Eur J Pharmacol; 1986 May; 124(1-2):207-8. PubMed ID: 3720840
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and antihypertensive properties of benzodioxane-pyridazinones and benzodioxane-dihydropyridazinones.
    Corsano S; Strappaghetti G; Codagnone A
    Arch Pharm (Weinheim); 1989 Nov; 322(11):833-5. PubMed ID: 2624530
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and pharmacological evaluation of some WB4101 analogues bearing a naphthodioxanic nucleus.
    Castagnino E; Strappaghetti G; Corsano S; Gallucci P; Brasili L; Giardinà D
    Farmaco Sci; 1984 Jul; 39(7):569-74. PubMed ID: 6148262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of pyrroxan and methylapogalanthamine on cerebral circulation and the brain's oxygen regime].
    Pogorelyĭ VE
    Farmakol Toksikol; 1981; 44(2):167-70. PubMed ID: 7274423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive properties of ketanserin (R 41 468).
    Vanhoutte PM; Van Nueten JM; Symoens J; Janssen PA
    Fed Proc; 1983 Feb; 42(2):182-5. PubMed ID: 6295821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of ATP-dependent K-channel related mechanisms in the antihypertensive and cough suppressant effects of the novel ACE inhibitor (2S, 3aS, 7aS)-1-(N2-nicotinoyl-L-lysyl-gamma-D-glutamyl)octahydro-1H- indole-2-carboxylic acid.
    Nagata S; Takeyama K; Hosoki K; Karasawa T
    Arzneimittelforschung; 1997 Jun; 47(6):726-30. PubMed ID: 9239450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular pharmacological characterization of novel 2,3-dimethyl-2-butylamine derivatives in rats.
    Chen YP; Qiu CR; Wang H
    Life Sci; 2004 Sep; 75(17):2131-42. PubMed ID: 15312756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment.
    Yamada S; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1980 Oct; 215(1):176-85. PubMed ID: 6109014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.